Literature DB >> 35913806

Virtual volunteering during the COVID-19 pandemic: case studies of virtual animal-assisted activities in a Singapore hospice.

Clara Kong1, Shu Min Camellia Soon1.   

Abstract

The COVID-19 pandemic has impacted the healthcare sector in many ways. Social safety measures in hospices in Singapore include cessation of non-essential services such as volunteering. Literature shows that volunteers are valuable in enhancing the quality of life of patients in receiving hospice services. They provide patients with needed companionship, and meaningful activities such as bringing their pets into the wards in animal-assisted activities. The rise of telehealth during the COVID-19 pandemic brought an increasing interest in virtual volunteering such as virtual animal-assisted activities (VAAA). However, there is currently a lack of literature on virtual volunteering as its increased demand is a recent trend. Virtual volunteering in a hospice in Singapore is described through two retrospective case studies of VAAA. These case studies showed that a therapeutic alliance can be effectively built via virtual platforms. Benefits of virtual volunteering include enabling continued service delivery and increased comfort for some patients as virtual interactions can be less intimidating as compared to interacting with an animal in real life. Virtual volunteering may be considered to complement face-to-face volunteering in end-of-life care as part of normal practice.

Entities:  

Keywords:  COVID-19; end-of-life care; hospice; virtual animal-assisted activities; virtual volunteering

Mesh:

Year:  2022        PMID: 35913806     DOI: 10.1080/15524256.2022.2105472

Source DB:  PubMed          Journal:  J Soc Work End Life Palliat Care        ISSN: 1552-4264


  1 in total

1.  Effects of the COVID-19 Pandemic on Animal-Assisted Activities in Pediatric Hospitals.

Authors:  Jessica Chubak; Gaia Pocobelli; Rebecca A Ziebell; Rene J Hawkes; Amanda Adler; Jennifer F Bobb; Danielle M Zerr
Journal:  J Pediatr Health Care       Date:  2022-09-30       Impact factor: 1.838

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.